Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis

Article English OPEN
Bath, Philip M.W. ; Martin, Renée H. ; Palesch, Yuko ; Cotton, Daniel ; Yusuf, Salim ; Sacco, Ralph L. ; Diener, Hans-Christoph ; Toni, Danilo ; Estol, Conrado ; Roberts, Robin (2009)

Background and Purpose—High blood pressure (BP) is common in acute ischemic stroke and associated independently\ud with a poor functional outcome. However, the management of BP acutely remains unclear because no large trials have\ud been completed.\ud \ud Methods—The factorial PRoFESS secondary stroke prevention trial assessed BP-lowering and antiplatelet strategies in\ud 20 332 patients; 1360 were enrolled within 72 hours of ischemic stroke, with telmisartan (angiotensin receptor\ud antagonist, 80 mg/d, n647) vs placebo (n713). For this nonprespecified subgroup analysis, the primary outcome was\ud functional outcome at 30 days; secondary outcomes included death, recurrence, and hemodynamic measures at up to 90\ud days. Analyses were adjusted for baseline prognostic variables and antiplatelet assignment.\ud \ud Results—Patients were representative of the whole trial (age 67 years, male 65%, baseline BP 147/84 mm Hg, small artery disease 60%, NIHSS 3) and baseline variables were similar between treatment groups. The mean time from stroke to recruitment was 58 hours. Combined death or dependency (modified Rankin scale: OR, 1.03; 95% CI, 0.84–1.26; P0.81;\ud death: OR, 1.05; 95% CI, 0.27–4.04; and stroke recurrence: OR, 1.40; 95% CI, 0.68–2.89; P0.36) did not differ between the treatment groups. In comparison with placebo, telmisartan lowered BP (141/82 vs 135/78 mmHg, difference 6 to 7 mmHg and 2 to 4 mmHg; P0.001), pulse pressure (3 to 4 mmHg; P0.002), and rate-pressure product (466 mmHg.bpm; P0.0004).\ud \ud Conclusion—Treatment with telmisartan in 1360 patients with acute mild ischemic stroke and mildly elevated BP appeared\ud to be safe with no excess in adverse events, was not associated with a significant effect on functional dependency, death, or recurrence, and modestly lowered BP.
  • References (26)
    26 references, page 1 of 3

    1. Yusuf S, Diener H-C, Sacco RL, Cotton D, Ounpuu S, Lawson WA, Palesch Y, Martin RH, Albers GW, Bath PM, Bornstein N, Chan BPL, Chen S-T, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick PB, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig G, P P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voight T, Weber M, Yoon B-W. for the PROFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359:1225-1237.

    2. Sacco RL, Diener H-C, Yusuf S, Cotton D, Ounpuu S, Lawton W, Palesch Y, Martin R, Albers GW, Bath PM, Bornstein N, Chan BPL, Chen S-T, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick PB, Gu V, Hermansson K, Hillbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voight T, Weber M, Yoon B-W. the PROFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359: 1238 -1251.

    3. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke. 2006;1:245-249.

    4. Geeganage C, Bath PMW. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews. 2008;Issue 4.

    5. Blood pressure in Acute Stroke Collaboration (BASC). Vasoactive drugs for acute stroke Cochrane Database of Systematic Reviews. 2000;Issue 4.

    6. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986;17:861- 864.

    7. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG. for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33:1315-1320.

    8. Carlsson A, Britton M. Blood pressure after stroke. A one-year follow-up study. Stroke. 1993;24:195-199.

    9. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43: 18 -24.

    10. Sprigg N, Gray LJ, Bath PMW, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson J-E, O'Neill D, Ringlestein B, van der Sande J-J, Lindenstrom E. for the TAIST investigators. Relationship between outcome and baseline blood pressure and other haemodynamic mreasures in acute ischaemic stroke: data from the TAIST trial. J Hypertens. 2006;24: 1413-1417.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark